Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice

The timing of vaccine availability is essential for an effective response to pandemic influenza. In 2009, vaccine became available after the disease peak, and this has motivated the development of next generation vaccine technologies for more rapid responses. The SAM(®) vaccine platform, now in pre-...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Hekele, Armin, Bertholet, Sylvie, Archer, Jacob, Gibson, Daniel G, Palladino, Giuseppe, Brito, Luis A, Otten, Gillis R, Brazzoli, Michela, Buccato, Scilla, Bonci, Alessandra, Casini, Daniele, Maione, Domenico, Qi, Zhi-Qing, Gill, John E, Caiazza, Nicky C, Urano, Jun, Hubby, Bolyn, Gao, George F, Shu, Yuelong, De Gregorio, Ennio, Mandl, Christian W, Mason, Peter W, Settembre, Ethan C, Ulmer, Jeffrey B, Craig Venter, J, Dormitzer, Philip R, Rappuoli, Rino, Geall, Andrew J
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2013
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3821287/
https://ncbi.nlm.nih.gov/pubmed/26038486
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emi.2013.54
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki